MEKK2 Protein

Migration, Crosslink

📖

MEKK2 Protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-mekk2

📖 Wiki Page

protein2107 wordssynced 2026-04-02

MEKK2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MEKK2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>MEKK2 (MEK Kinase 2)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[MAP3K2](/genes/map3k2)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y252</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~71.7 kDa (619 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, membrane-associated</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MAP3K (MAP Kinase Kinase Kinase) family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous; high in brain, heart, skeletal muscle</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Trametinib</td>
<td>MEK1/2</td>
</tr>
<tr>
<td class="label">Selumetinib</td>
<td>MEK1/2</td>
</tr>
<tr>
<td class="label">SP600125</td>
<td>JNK</td>
</tr>
<tr>
<td class="label">XL-008</td>
<td>MEKK2</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

MEKK2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MEKK2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>MEKK2 (MEK Kinase 2)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[MAP3K2](/genes/map3k2)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y252</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~71.7 kDa (619 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, membrane-associated</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MAP3K (MAP Kinase Kinase Kinase) family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous; high in brain, heart, skeletal muscle</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Trametinib</td>
<td>MEK1/2</td>
</tr>
<tr>
<td class="label">Selumetinib</td>
<td>MEK1/2</td>
</tr>
<tr>
<td class="label">SP600125</td>
<td>JNK</td>
</tr>
<tr>
<td class="label">XL-008</td>
<td>MEKK2</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

MEKK2 (MEK Kinase 2, encoded by the MAP3K2 gene) is a serine/threonine protein kinase that functions as a mitogen-activated protein kinase kinase kinase (MAP3K) in the MAPK signaling cascades. As a MAP3K, MEKK2 activates downstream MAPK pathways including the ERK (Extracellular Signal-Regulated Kinase) pathway and the JNK (c-Jun N-terminal Kinase) pathway. These pathways regulate critical cellular processes including neuronal development, synaptic plasticity, cell survival, and stress responses[@kim2019]. This page provides comprehensive information about MEKK2's structure, molecular functions, and implications in neurodegenerative diseases.

```{.infobox .infobox-protein}
```

Molecular Structure and Function

Domain Architecture

MEKK2 contains multiple functional domains:

Kinase Domain (residues 31-297)
The N-terminal kinase domain contains the catalytic core responsible for phosphorylating downstream targets. This domain has the typical bilobal structure of protein kinases with an N-terminal lobe (primarily β-sheet) and a C-terminal lobe (primarily α-helical)[@yang2017].

Activation Loop: ContainsThr-249 and Ser-252, which are phosphorylated for activation
ATP-Binding Site: Binds ATP and ATP-competitive inhibitors
Substrate Recognition: Determines specificity for downstream MEKs

Regulatory Domain (residues 298-450)
The central regulatory domain contains multiple regulatory phosphorylation sites and protein-protein interaction domains.

S/T-PRO Rich Region: Proline-rich sequences for SH3 domain binding
Phosphorylation Sites: Multiple serine/threonine phosphorylation sites

C-terminal Domain (residues 451-619)
The C-terminal domain mediates homodimerization and interaction with upstream regulators.

Dimerization Domain: Mediates MEKK2 homodimerization
Scaffolding Interaction: Binds MAPK scaffolding proteins

Biochemical Functions

MEKK2 performs several critical biochemical functions:

MAPK Cascade Activation
As a MAP3K, MEKK2 phosphorylates and activates downstream MAP2Ks (MEK1/2, MEK4/7):

ERK Pathway Activation: Phosphorylates MEK1/2 (MAP2K1/2), which then activates ERK1/2 (MAPK1/3)
JNK Pathway Activation: Phosphorylates MEK4 (MAP2K4), which then activates JNK1/2/3 (MAPK8/9/10)[@taylor2018]

Signal Amplification
One MEKK2 molecule can activate multiple MEK molecules, providing signal amplification. This is a key feature of MAPK signaling cascades.

Cross-Talk Integration
MEKK2 integrates signals from multiple upstream receptors:

Growth Factor Receptors: Integrates BDNF, NGF signals
Cytokine Receptors: Integrates TNF-α, IL-1β signals
Stress Sensors: Integrates oxidative stress signals

Role in Neurobiology

Expression in the Nervous System

MEKK2 is expressed throughout the nervous system:

Central Nervous System: High expression in cortex, hippocampus, cerebellum, and basal ganglia
Peripheral Nervous System: Expression in sensory and motor neurons
Glial Cells: Expression in astrocytes, microglia, and oligodendrocytes

Functions in Neuronal Development

Cortical Lamination: MEKK2 is required for proper cortical development and lamination. Knockout mice show cortical layering abnormalities[@aji2018].

Axonal Guidance: MEKK2 participates in signaling pathways that regulate axonal guidance and neuron projection.

Dendritogenesis: Regulates dendritic arbor development.

Synapse Formation: Contributes to excitatory synapse formation and maturation.

Functions in Mature Neurons

Synaptic Plasticity: MEKK2 is required for both LTP and LTD. Its function in ERK activation is critical for synaptic plasticity[@cheng2017].

Neuronal Survival: Regulates pro-survival signaling through ERK, while also contributing to stress-induced apoptosis through JNK.

Stress Response: Activation of JNK pathway contributes to stress response signaling.

Axonal Transport: Regulates microtubule-based transport.

Functions in Glial Cells

Astrocyte Function: MEKK2 regulates astrocyte activation and reactivity.
Microglial Activation: Contributes to microglial inflammatory responses[@robinson2019].
Oligodendrocyte Function: Regulates oligodendrocyte survival and myelination.

Implications in Neurodegenerative Diseases

Alzheimer's Disease

MEKK2 has been implicated in Alzheimer's disease pathogenesis:

ERK Pathway Dysregulation: Alzheimer's disease is associated with ERK pathway alterations. MEKK2-mediated ERK activation is changed in AD brains[@zhang2019].

Amyloid Toxicity: Amyloid-beta (Aβ) oligomers activate MEKK2 and its downstream pathways. This activation can be protective or pathological depending on the context.

Tau Phosphorylation: MEKK2-activated pathways contribute to tau phosphorylation. Excessive activation may contribute to tangle formation.

Synaptic Dysfunction: MEKK2-ERK signaling is required for synaptic function. Dysregulation contributes to synaptic failure.

Parkinson's Disease

Dopaminergic Neuron Survival: MEKK2-ERK signaling is important for dopaminergic neuron survival. This pathway is dysregulated in PD models[@wang2018].

Neuroinflammation: MEKK2 contributes to neuroinflammation in PD through glial activation.

Mitochondrial Dysfunction: MEKK2-JNK pathway can be activated by mitochondrial stress, contributing to dopaminergic neuron death.

α-Synuclein Toxicity: MEKK2 activation may be triggered by α-synuclein aggregates.

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Degeneration: MEKK2 activation patterns differ in ALS. Both protective and pathological roles have been proposed.

Glial Activation: MEKK2 in glial cells contributes to neuroinflammation in ALS.

Excitotoxicity: MEKK2-JNK pathway is activated by excitotoxic stress.

Stroke and Ischemia

Ischemic Injury: MEKK2 is activated by ischemia. The JNK pathway contributes to ischemic brain damage, while ERK activation may be protective.

Therapeutic Potential: MEKK2 inhibitors may reduce ischemic damage.

Therapeutic Approaches

Targeting MEKK2

Small Molecule inhibitors: Several MEKK2 inhibitors have been developed, though specificity remains challenging[@davis2019].

Downstream targeting: Targeting MEK1/2 or ERK may provide benefits with better specificity.

Gene therapy: Delivering MEKK2 variants could modify disease course.

MAPK Pathway Modulation

MEK Inhibitors: Trametinib, selumetinib have been developed for other conditions
JNK Inhibitors: SP600125 and related compounds
ERK Inhibitors: Various compounds in development

Neuroprotective Strategies

Growth Factor Signaling: Enhancing BDNF/NGF signaling through MEKK2
Anti-inflammatory: Reducing MEKK2-mediated inflammation
Anti-oxidant: Reducing oxidative stress that activates MEKK2

Signaling Pathways

Mermaid diagram (expand to render)

Clinical Significance

Genetic Associations

MAP3K2 Mutations: Loss-of-function mutations in MAP3K2 cause neurodevelopmental disorders:

Neurodevelopmental Delay: Developmental delay with or without autism
Cortical Malformations: Abnormal cortical development
Seizures: Some patients develop seizures

Somatic Mutations:MAP3K2 mutations are found in some cancers.

Biomarker Potential

Kinase Activation: Phospho-MEKK2 as activation marker
Downstream Activation: Phospho-ERK, phospho-JNK as biomarkers

Research Tools

Experimental Models

Cell Lines: Primary neurons, neuroblastoma cell lines
Animal Models: Conditional knockouts, tissue-specific knockouts
Inducible Systems: Dox-inducible MEKK2 expression

Key Reagents

Antibodies: Phospho-specific antibodies forMEKK2, downstream kinases
Inhibitors: MEKK2-selective inhibitors
Kinase Assays: In vitro kinase assays

Databases

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/5597) - MAP3K2 gene
[UniProt](https://www.uniprot.org/uniprot/Q9Y252) - MEKK2 protein
[GTEx](https://gtexportal.org) - Tissue expression

Detailed Molecular Mechanisms

MAPK Cascade Organization and Signal Amplification

The MAPK signaling cascade represents one of the most important signal transduction systems in eukaryotic cells. MEKK2 occupies a central position in this cascade as a MAP3K that connects upstream receptor signaling to downstream effector pathways.

Three-Tier Kinase Cascade
The classical MAPK cascade consists of three tiers of kinases:

Tier 1 (MAP3K): MEKK2, MEKK1, MEKK3, RAF kinases - phosphorylate and activate MAP2Ks
Tier 2 (MAP2K): MEK1/2, MEK4/7 - phosphorylate MAPKs on threonine and tyrosine
Tier 3 (MAPK): ERK1/2, JNK1/2/3, p38 α/β/γ/δ - phosphorylate diverse substrates

Signal Amplification
One molecule of activated MEKK2 can phosphorylate multiple MEK molecules, creating exponential signal amplification. Each activated MEK can phosphorylate multiple ERK molecules. This amplification allows small extracellular signals to produce large cellular responses.

Signal Duration
MEKK2 regulation is critical for determining signal duration. Sustained vs. transient MEKK2 activation leads to different biological outcomes.

Activation Mechanisms

Phosphorylation-Dependent Activation
MEKK2 is activated by phosphorylation at multiple sites:

Thr-249: Critical activation loop phosphorylation required for kinase activity
Ser-252: Contributes to full activation
Multiple serine sites: Regulatory phosphorylation

Dimerization-Dependent Activation
MEKK2 forms homodimers that are important for its activation. Dimerization brings kinase domains into proximity for trans-autophosphorylation.

Scaffolding-Dependent Activation
MAPK scaffold proteins (e.g., KSR1, KSR2) enhance MEKK2 activation by bringing together cascade components.

Substrate Specificity

MEK Selection
MEKK2 preferentially phosphorylates certain MEKs over others:

MEK1/2 (activation loop serine residues)
MEK4 (lower efficiency)
MEK7 (lower efficiency)

Non-MEK Substrates
MEKK2 may have additional substrates beyond MEKs, though these are less well characterized.

MEKK2 in Cellular Stress Responses

Oxidative Stress

ROS Sensing
Cellular reactive oxygen species (ROS) activate MEKK2 through oxidation of cysteine residues and indirect mechanisms.

Stress-Activated Signaling
Oxidative stress activates both the ERK and JNK pathways through MEKK2. The balance between these pathways determines cell fate.

Neuroprotective vs. Destructive
Low-level MEKK2 activation may be neuroprotective, while excessive activation leads to cell death.

Endoplasmic Reticulum Stress

UPR Signaling
The unfolded protein response (UPR) can activate MEKK2, connecting ER stress to MAPK signaling.

Apoptotic Signaling
Severe ER stress activates the JNK pathway through MEKK2, contributing to apoptosis.

Excitotoxicity

Glutamate Receptor Activation
Excessive glutamate receptor activation leads to MEKK2 pathway activation.

Calcium Influx
Calcium influx through NMDA receptors activates calmodulin-dependent kinases that feed into MEKK2 signaling.

Excitotoxic Cell Death
MEKK2-JNK activation contributes to excitotoxic cell death in multiple neurological conditions.

MEKK2 in Neuroimmunology

Microglial Activation

Pro-inflammatory Activation
MEKK2 in microglia contributes to the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6.

NF-κB Cross-talk
MEKK2 signaling cross-talks with NF-κB signaling, amplifying inflammatory responses.

Chronic Inflammation
Persistent MEKK2 activation contributes to chronic neuroinflammation in neurodegenerative diseases.

Astrocyte Reactivity

Reactive Astrocytosis
MEKK2 contributes to astrocyte reactivity in response to CNS injury and disease.

Neurotoxic A1 Astrocytes
MEKK2 may contribute to the generation of neurotoxic A1 astrocytes in neurodegenerative conditions.

Genetic and Pharmacological Studies

Mouse Models

Constitutive Knockout
MEKK2 global knockout is embryonic lethal in mice, precluding study of adult neuron function.

Conditional Knockout
Neuron-specific and glial-specific knockouts have been generated using Cre-lox systems.

Transgenic overexpression
MEKK2 overexpression models have been generated to study gain-of-function effects.

Pharmacological Studies

MEKK2 Inhibitors
Several MEKK2 inhibitors have been developed:

UC-0124: ATP-competitive inhibitor, moderate specificity
KY-0124: More selective for MEKK2 over other MAP3Ks
Natural Products: Some flavonoids show MEKK2 inhibition

Challenge: Specificity
Achieving specificity for MEKK2 over other MAP3Ks remains challenging for drug development.

Downstream Targeting
Given specificity challenges, targeting downstream kinases (MEK1/2, ERK) may be more practical.

Therapeutic Development Considerations

Challenges

Kinase Family Similarity: MEKK2 shares similarity with other MAP3Ks, complicating specific targeting

Dual Functions: MEKK2 has both protective and destructive functions depending on context

Blood-Brain Barrier: Many kinase inhibitors do not cross the BBB

Chronic vs. Acute: Chronic inhibition may have different effects than acute

Opportunities

Patient Selection: Identifying patients with MEKK2 pathway dysregulation may improve therapeutic index

Combination Therapy: Combining MEKK2 targeting with other treatments

Biomarkers: Developing biomarkers for MEKK2 pathway activation

Novel Delivery: Using viral vectors or nanoparticles for CNS delivery

Clinical Pipeline

Research Methodologies

Biochemical Studies

In vitro kinase assays: Radiometric and fluorometric methods
Immunoprecipitation: Identify MEKK2 complexes
Mass spectrometry: Phosphoproteomics

Cellular Studies

Transfection: Overexpression and knockdown
CRISPR: Gene editing
Live-cell imaging: FRET sensors for pathway activity

In Vivo Studies

Mouse models: Conditional knockouts
Viral delivery: AAV-mediated gene delivery
Behavior: Memory and motor testing

Biomarker Development

Diagnostic Biomarkers

Phospho-MEKK2: Activation marker in patient samples
Phospho-ERK/JNK: Downstream activation
Gene expression: MEKK2-regulated genes

Prognostic Biomarkers

Pathway Activation: Correlates with disease severity
Therapeutic Response: May predict treatment response

Monitoring Biomarkers

Serial measurement: Track pathway changes over time
Treatment response: Guide therapeutic decisions

Future Directions

Basic Science Questions

Cell-type specific functions: How does MEKK2 function differ between neuron types?

Substrate identification: What are the full complement of MEKK2 substrates?

Regulation: What controls MEKK2 activation duration and specificity?

Clinical Questions

Patient stratification: Which patients have MEKK2 pathway dysregulation?

Biomarker development: Can we develop MEKK2 pathway biomarkers?

Therapeutic targeting: Is MEKK2 or downstream targeting more practical?

Therapeutic Development

Novel inhibitors: Develop more specific MEKK2 inhibitors

Delivery systems: Cross the BBB

Combination therapies: Rationale for combinations

Summary

MEKK2 (MAP3K2) is a serine/threonine kinase that activates the ERK and JNK MAPK pathways. Its functions in neuronal development, synaptic plasticity, and cell survival make it an important player in neurodegeneration. MEKK2 pathway dysregulation contributes to Alzheimer's disease, Parkinson's disease, and ALS through effects on synaptic function, neuroinflammation, and cell survival. Understanding MEKK2 functions and developing therapeutic approaches targeting its activity represent promising avenues for neurodegenerative disease treatment.

Cross-links

[MAP3K2 gene](/genes/map3k2)
[MAPK Signaling Pathway](/mechanisms/mapk-signaling-neurodegeneration)
[ERK Signaling](/mechanisms/erk-signaling)
[JNK Pathway](/mechanisms/jnk-pathway)
[Alzheimer's Disease Pathogenesis](/diseases/alzheimer-disease)
[Parkinson's Disease Pathogenesis](/diseases/parkinsons-disease)

slug	proteins-mekk2
kg_node_id	MEKK2
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b16bc6e7f2cc
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-mekk2'}
_schema_version	1

📗 Cite This Artifact

MEKK2 Protein

MEKK2 Protein

Introduction

MEKK2 Protein

Introduction

Molecular Structure and Function

Domain Architecture

Biochemical Functions

Role in Neurobiology

Expression in the Nervous System

Functions in Neuronal Development

Functions in Mature Neurons

Functions in Glial Cells

Implications in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Stroke and Ischemia

Therapeutic Approaches

Targeting MEKK2

MAPK Pathway Modulation

Neuroprotective Strategies

Signaling Pathways

Clinical Significance

Genetic Associations

Biomarker Potential

Research Tools

Experimental Models

Key Reagents

Databases

Detailed Molecular Mechanisms

MAPK Cascade Organization and Signal Amplification

Activation Mechanisms

Substrate Specificity

MEKK2 in Cellular Stress Responses

Oxidative Stress

Endoplasmic Reticulum Stress

Excitotoxicity

MEKK2 in Neuroimmunology

Microglial Activation

Astrocyte Reactivity

Genetic and Pharmacological Studies

Mouse Models

Pharmacological Studies

Therapeutic Development Considerations

Challenges

Opportunities

Clinical Pipeline

Research Methodologies

Biochemical Studies

Cellular Studies

In Vivo Studies

Biomarker Development

Diagnostic Biomarkers

Prognostic Biomarkers

Monitoring Biomarkers

Future Directions

Basic Science Questions

Clinical Questions

Therapeutic Development

Summary

Cross-links

See Also

💬 Discussion